Maxwell Biosciences

Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules. The company's platform effectively destroys viruses, bacteria, fungi, and some cancers, while avoiding healthy cells in human tissues and animal studies, where compounds imitate key components of the immune system, enabling healthcare professionals to treat formerly untreatable conditions.

Edward Rudnic Ph.D

COO and Head of Research and Development

1 past transactions

MaxWell Clinic

Acquisition in 2017
Patient-centered, proactive medicine that maximizes the pursuit of your dreams through innovative diagnostics and technologies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.